Cymbalta

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 2004
gptkbp:ATCCode gptkb:N06AX21
gptkbp:blackBoxWarning suicidal thoughts and behaviors in children, adolescents, and young adults
gptkbp:CASNumber gptkb:136434-34-9
gptkbp:chemicalFormula gptkb:C18H19NOS
gptkbp:contraindication concurrent use with MAO inhibitors
uncontrolled narrow-angle glaucoma
gptkbp:drugClass norepinephrine reuptake inhibitor
gptkbp:eliminationHalfLife 12 hours
gptkbp:excretion urine
gptkbp:form capsule
gptkbp:genericAvailable yes
gptkbp:genericName gptkb:duloxetine
https://www.w3.org/2000/01/rdf-schema#label Cymbalta
gptkbp:interactsWith gptkb:beer
gptkb:MAO_inhibitors
gptkb:SSRIs
CYP1A2 inhibitors
gptkbp:legalStatus prescription only
gptkbp:manufacturer gptkb:Eli_Lilly_and_Company
gptkbp:marketedAs gptkb:United_States
gptkbp:mechanismOfAction inhibits reuptake of serotonin and norepinephrine
gptkbp:metabolism liver
gptkbp:patentExpired 2013 (US)
gptkbp:pregnancyCategory C (US)
gptkbp:prescribes adults
some adolescents (off-label)
gptkbp:proteinBinding 96%
gptkbp:riskFactor gptkb:serotonin_syndrome
suicidal thoughts (in young adults)
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
constipation
fatigue
drowsiness
dry mouth
sexual dysfunction
decreased appetite
increased sweating
gptkbp:synonym gptkb:duloxetine_hydrochloride
gptkbp:usedFor gptkb:generalized_anxiety_disorder
gptkb:major_depressive_disorder
fibromyalgia
chronic musculoskeletal pain
diabetic peripheral neuropathic pain
gptkbp:bfsParent gptkb:Eli_Lilly_and_Company
gptkbp:bfsLayer 5